SWTX logo

SpringWorks Therapeutics (SWTX) EBIT

annual EBIT:

-$278.13M+$64.88M(+18.92%)
December 31, 2024

Summary

  • As of today (July 1, 2025), SWTX annual earnings before interest & taxes is -$278.13 million, with the most recent change of +$64.88 million (+18.92%) on December 31, 2024.
  • During the last 3 years, SWTX annual EBIT has fallen by -$104.66 million (-60.34%).
  • SWTX annual EBIT is now -1404.14% below its all-time high of -$18.49 million, reached on December 31, 2018.

Performance

SWTX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXincome statement metrics

quarterly EBIT:

-$82.19M-$847.00K(-1.04%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX quarterly earnings before interest & taxes is -$82.19 million, with the most recent change of -$847.00 thousand (-1.04%) on March 31, 2025.
  • Over the past year, SWTX quarterly EBIT has increased by +$11.74 million (+12.50%).
  • SWTX quarterly EBIT is now -832.59% below its all-time high of $11.22 million, reached on December 31, 2020.

Performance

SWTX quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXincome statement metrics

TTM EBIT:

-$266.39M+$11.74M(+4.22%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX TTM earnings before interest & taxes is -$266.39 million, with the most recent change of +$11.74 million (+4.22%) on March 31, 2025.
  • Over the past year, SWTX TTM EBIT has increased by +$92.86 million (+25.85%).
  • SWTX TTM EBIT is now -4993.48% below its all-time high of -$5.23 million, reached on September 30, 2018.

Performance

SWTX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

SWTX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+18.9%+12.5%+25.9%
3 y3 years-60.3%-33.7%-29.8%
5 y5 years-369.5%-409.5%-288.0%

SWTX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-60.3%+18.9%-83.0%+16.5%-17.3%+25.9%
5 y5-year-500.4%+18.9%-832.6%+16.5%-475.1%+25.9%
alltimeall time-1404.1%+18.9%-832.6%+16.5%-4993.5%+25.9%

SWTX EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$82.19M(+1.0%)
-$266.39M(-4.2%)
Dec 2024
-$278.13M(-18.9%)
-$81.34M(+40.4%)
-$278.13M(-5.8%)
Sep 2024
-
-$57.94M(+29.0%)
-$295.25M(-8.1%)
Jun 2024
-
-$44.92M(-52.2%)
-$321.31M(-10.6%)
Mar 2024
-
-$93.93M(-4.6%)
-$359.25M(+4.7%)
Dec 2023
-$343.01M(+22.2%)
-$98.46M(+17.2%)
-$343.01M(+6.2%)
Sep 2023
-
-$84.00M(+1.4%)
-$323.00M(+3.9%)
Jun 2023
-
-$82.85M(+6.6%)
-$310.75M(+4.7%)
Mar 2023
-
-$77.70M(-1.0%)
-$296.90M(+5.8%)
Dec 2022
-$280.67M(+61.8%)
-$78.45M(+9.4%)
-$280.67M(+8.8%)
Sep 2022
-
-$71.74M(+4.0%)
-$258.02M(+13.6%)
Jun 2022
-
-$69.01M(+12.3%)
-$227.17M(+10.7%)
Mar 2022
-
-$61.47M(+10.2%)
-$205.18M(+18.3%)
DateAnnualQuarterlyTTM
Dec 2021
-$173.47M(+274.5%)
-$55.80M(+36.4%)
-$173.47M(+63.0%)
Sep 2021
-
-$40.90M(-13.0%)
-$106.45M(+22.1%)
Jun 2021
-
-$47.02M(+58.0%)
-$87.15M(+45.4%)
Mar 2021
-
-$29.76M(-365.2%)
-$59.95M(+29.4%)
Dec 2020
-$46.32M(-21.8%)
$11.22M(-152.0%)
-$46.32M(-38.2%)
Sep 2020
-
-$21.59M(+8.9%)
-$74.91M(+9.1%)
Jun 2020
-
-$19.82M(+22.9%)
-$68.65M(+7.8%)
Mar 2020
-
-$16.13M(-7.1%)
-$63.68M(+7.5%)
Dec 2019
-$59.24M(+220.4%)
-$17.37M(+13.3%)
-$59.24M(+22.6%)
Sep 2019
-
-$15.33M(+3.2%)
-$48.31M(+26.4%)
Jun 2019
-
-$14.85M(+27.1%)
-$38.22M(+63.6%)
Mar 2019
-
-$11.69M(+81.3%)
-$23.36M(+100.1%)
Dec 2018
-$18.49M
-$6.45M(+23.3%)
-$11.68M(+123.3%)
Sep 2018
-
-$5.23M
-$5.23M

FAQ

  • What is SpringWorks Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics annual EBIT year-on-year change?
  • What is SpringWorks Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics quarterly EBIT year-on-year change?
  • What is SpringWorks Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics TTM EBIT year-on-year change?

What is SpringWorks Therapeutics annual earnings before interest & taxes?

The current annual EBIT of SWTX is -$278.13M

What is the all time high annual EBIT for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high annual earnings before interest & taxes is -$18.49M

What is SpringWorks Therapeutics annual EBIT year-on-year change?

Over the past year, SWTX annual earnings before interest & taxes has changed by +$64.88M (+18.92%)

What is SpringWorks Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of SWTX is -$82.19M

What is the all time high quarterly EBIT for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high quarterly earnings before interest & taxes is $11.22M

What is SpringWorks Therapeutics quarterly EBIT year-on-year change?

Over the past year, SWTX quarterly earnings before interest & taxes has changed by +$11.74M (+12.50%)

What is SpringWorks Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of SWTX is -$266.39M

What is the all time high TTM EBIT for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high TTM earnings before interest & taxes is -$5.23M

What is SpringWorks Therapeutics TTM EBIT year-on-year change?

Over the past year, SWTX TTM earnings before interest & taxes has changed by +$92.86M (+25.85%)
On this page